Katja Sibylle Mühlberg

Dr. Katja Sibylle Mühlberg

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2023 in Hamostaseologie
Verified
Journal Article
Closed access
PDF file
KMKatja Sibylle Mühlberg
Katja Sibylle Mühlberg
Splanchnic or visceral vein thromboses (VVTs) are atypical thrombotic entities and include thrombosis of the portal vein, hepatic veins (Budd-Chiari syndrome), mesenteric veins, and splenic vein. All VVTs have in common high 30-day mortality up to 20% and it seems to be difficult to diagnose VVT early because of their rarity and their wide spectrum of unspecific symptoms. VVTs are often associated with myeloproliferative neoplasia, thrombophilia, and liver cirrhosis. VVT is primarily diagnosed by sonography and/or computed tomography. In contrast to venous thromboembolism, D-dimer testing is neither established nor helpful. Anticoagulation is the first-line therapy in patients with stable circulation and no evidence of organ complications. Anticoagulation improves significantly recanalization rates and stops the progress of thrombosis. Low-molecular-weight heparin, vitamin K antagonists, as well as direct-acting oral anticoagulants are possible anticoagulants, but it is noteworthy to be aware that all recommendations supporting the off-label use of anticoagulants are based on poor evidence and consist predominantly of case series, observational studies, or studies with small case numbers. When choosing a suitable anticoagulation, the individual risk of bleeding and thrombosis must be weighted very carefully. In cases of bleeding, bowel infarction, or other complications, the optimal therapy should be determined on a case-by-case basis by an experienced multidisciplinary team involving a surgeon. Besides anticoagulation, there are therapeutic options including thrombectomy, balloon angioplasty, stenting, transjugular placement of an intrahepatic portosystemic shunt, liver transplantation, and ischemic bowel resection. This article gives an overview of current diagnostic and therapeutic strategies.

25 March 2026 in British Journal of Dermatology
Verified
Journal Article
Open access
KMKatja Sibylle Mühlberg
Katja Sibylle Mühlberg
RSRobin Schürfeld
Robin Schürfeld
PKPatricia Kieser
Patricia Kieser
SUSimone Uhlemann
Simone Uhlemann
MSMichael Stumvoll
Michael Stumvoll
TEThomas Ebert
Thomas Ebert
Lipoedema is a chronic adipose tissue disorder often misdiagnosed as obesity due to overlapping symptoms and a lack of biomarkers. In this study, we analysed 13 adipocytokines in 79 women and identified chemerin, FGF21 and adiponectin as key biomarkers for distinguishing lipoedema. Decision tree models achieved up to 95% sensitivity, supporting the potential of these biomarkers for improving diagnostic accuracy, particularly in women with overweight or obesity.

1 March 2022 in Vasa
Verified
Journal Article
Closed access
KMKatja Sibylle Mühlberg
Katja Sibylle Mühlberg
MSMuriel G. Sprynger
Muriel G. Sprynger

1 November 2022 in Vasa
Verified
Journal Article
Closed access
LSLevani Sopromadze
Levani Sopromadze
KMKatja Sibylle Mühlberg
Katja Sibylle Mühlberg

27 September 2023 in DMW - Deutsche Medizinische Wochenschrift
Verified
Journal Article
Closed access
PDF file
KMKatja Sibylle Mühlberg
Katja Sibylle Mühlberg
Der unmittelbare und langfristige Erfolg endovaskulärer und offen chirurgischer Revaskularisierungsverfahren wird entscheidend von der konservativen Therapie der pAVK bestimmt. Die „schonende, bewahrende“ Behandlung soll dabei als absolute Basistherapie verstanden werden, weil sie die „Big Five“ der Atherosklerose-Risikofaktoren adressiert. Dieser Beitrag präsentiert das Spektrum sowohl medikamentöser als auch nicht medikamentöser Strategien. Today, peripheral artery disease (PAD) is treated with the most modern endovascular and open surgical revascularisation procedures. But the short and long-term success of these interventions is decisively determined by the conservative therapy of PAD, which therefore represents the absolute basic therapy of every PAD. Conservative treatment addresses the "Big Five" of atherosclerosis risk factors: smoking, lack of exercise and overweight, diabetes, hypertension, and hyperlipidemia. Despite the knowledge that PAD as a peripheral manifestation of the systemic atherosclerosis needs the same risk factor management as e.g., coronary heart disease, not even every second PAD patient in Germany receives the required therapy. This paper presents the spectrum of both drug and non-drug strategies and focuses on aspects such as platelet inhibition and anticoagulation regimes, lipid-lowering options as well as the benefits and necessity of exercise programs to promote collaterals and improve quality of life by extending the pain-free walking distance. Proven strategies to overcome smoking addiction, use and purpose of vasoactive substances are highlighted as well as the potential risks of diabetic foot syndrome for limb salvage and prevention of wounds. Received: 31 May 2023 Accepted: 10 July 2023 Article published online: 27 September 2023 © 2023. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

23 September 2024 in DMW - Deutsche Medizinische Wochenschrift
Verified
Journal Article
Closed access
PDF file
KMKatja Sibylle Mühlberg
Katja Sibylle Mühlberg
Das postthrombotische Syndrom PTS entsteht, wenn nach stattgehabter Thrombose eine relevante Restthrombuslast verbleibt und/oder Venenklappen in ihrer Funktion gestört sind. Das Wissen um die verschiedenen Typen des PTS generiert individualisiert therapeutische und sekundärprophylaktische Ansätze. Die sofortige Kompression, Bewegung in Kompression und Antikoagulation sind maßgeblich für die Verhinderung und das Outcome postthrombotischer Syndrome. The post-thrombotic syndrome PTS occurs when a relevant residual thrombus load remains after a deep vein thrombosis and/or the function of the venous valves is disturbed. The knowledge of the different types of PTS generates individualized therapeutic and secondary prophylactic approaches. Immediate compression, movement in compression garments and an effective anticoagulation are crucial for both the prevention and the outcome of post thrombotic syndromes. Article published online: 23 September 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany